Protara Therapeutics, Inc.
TARA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $13 | $31 | $91 | $163 |
| Short-Term Investments | $120 | $91 | $33 | $7 |
| Receivables | $1 | $1 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $2 | $2 | $2 |
| Total Curr. Assets | $136 | $125 | $127 | $172 |
| Property Plant & Equip (Net) | $4 | $5 | $5 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $3 | $3 | $3 | $3 |
| Long-Term Investments | $1 | $23 | $33 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $1 |
| Total NC Assets | $9 | $32 | $42 | $9 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $145 | $157 | $169 | $181 |
| Liabilities | – | – | – | – |
| Payables | $5 | $5 | $2 | $4 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $3 | $4 | $5 |
| Total Curr. Liab. | $10 | $10 | $7 | $11 |
| LT Debt | $2 | $3 | $3 | $3 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $2 | $3 | $3 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $4 | $4 | $4 |
| Total Liabilities | $12 | $13 | $10 | $14 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$285 | -$272 | -$257 | -$245 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $417 | $416 | $415 | $412 |
| Total Equity | $132 | $144 | $158 | $167 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $145 | $157 | $169 | $181 |
| Net Debt | -$9 | -$28 | -$87 | -$158 |